
$111.04M | |
$1.20 | |
$53.10 | |
$0.71 | |
$1.20 | |
$+0.29 | |
+24.17% | |
7M |
InflaRx N.V (IFRX) is currently trading at $1.54 as of 2026-04-17 19:34:00, reflecting a +24.17% move ($+0.29) from the previous close.
In the short term, the stock has returned +68.87% over the past four weeks. Over the last 12 months, InflaRx N.V has recorded a +44.91% price change, indicating a Strong performance relative to the broader market.
Over the past seven days, InflaRx N.V has traded within a short-term range shaped by market sentiment in the sector. During this period, the stock moved from its previous closing price of $1.00 to the latest recorded price of $1.54, reflecting an intraday change of +24.17%. Daily movements highlight shifts in trading volume (7,065,151), investor positioning, and reactions to macroeconomic updates.
From a momentum standpoint, IFRX has delivered a +68.87% return over the past month and a +44.91% change in the last 12 months, indicating a Strong trend relative to its broader sector peers.
You can buy and trade IFRX on MEXC in three simple steps:
InflaRx NV is a biopharmaceutical company applying proprietary technologies to discover, develop and commercialize potent and specific inhibitors of the complement activation factor known as C5a and its receptor C5aR. With its therapeutic product candidates, vilobelimab and izicopan, the company targets C5a and its receptor C5aR to selectively inhibit the powerful inflammatory response observed in a wide variety of autoimmune and other inflammatory diseases elicited through C5a/C5aR activation. Its product candidate, GOHIBIC (vilobelimab), is a novel intravenously delivered anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
| Industry | -- |
| Employees | 65 |
| Sector | -- |
| Company Website |
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Amount
1 IFRX = 1.536 USD